Interactions between pharmacokinetics of paclitaxel, physical activity and body composition in breast cancer. Search for starting points to reduce dose limiting toxicities

Wuyts, S. (Contributor)
Adriaenssens, N. (Supervisor)
Beckwée, D. (Contributor)
Provyn, S. (Contributor)
Steurbaut, S. (Contributor)
de Haar-Holleman, A. (Contributor)
Lanckmans, K. (Contributor)
Jan Van Bocxlaer (Contributor)
An Vermeulen (Contributor)
Elke Gasthuys (Contributor)
Sofie Vande Casteele (Contributor)

Activity: Other › Written proposal

Description

Written proposol for translational research project (Kom op tegen Kanker 2022)

Period	24 Jan 2024
Degree of Recognition	National

Related content

Research output
Rethinking Chemotherapy Dosing: The impact of body composition, physical activity, and pharmacokinetics on dose-limiting toxicities in breast cancer patients.
Research output: Unpublished contribution to conference › Poster
Dose-Limiting Toxicities of Paclitaxel in Breast Cancer Patients: Studying Interactions Between Pharmacokinetics, Physical Activity, and Body Composition—A Protocol for an Observational Cohort Study
Research output: Contribution to journal › Article › peer-review

Projects
Interactions between pharmacokinetics of paclitaxel, physical activity and body composition in breast cancer. Search for starting points to reduce dose limiting toxicities.
Project: Fundamental